肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

蒽环类药物心脏毒性防治共识

2011-11-13 MedSci原创 MedSci原创

蒽环类心脏毒性
关注

蒽环类药物心脏毒性防治共识

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=3702, encodeId=31f73e0287, content=不错！, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2d50162, createdName=janev21, createdTime=Thu Nov 17 19:01:00 CST 2011, time=2011-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418105, encodeId=7b7514181059a, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ab3331025, createdName=cy0325, createdTime=Mon Nov 14 15:06:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521681, encodeId=086b1521681da, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Mon Nov 14 15:06:00 CST 2011, time=2011-11-14, status=1, ipAttribution=)]
    2011-11-17 janev21

    不错！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=3702, encodeId=31f73e0287, content=不错！, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2d50162, createdName=janev21, createdTime=Thu Nov 17 19:01:00 CST 2011, time=2011-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418105, encodeId=7b7514181059a, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ab3331025, createdName=cy0325, createdTime=Mon Nov 14 15:06:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521681, encodeId=086b1521681da, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Mon Nov 14 15:06:00 CST 2011, time=2011-11-14, status=1, ipAttribution=)]
    2011-11-14 cy0325

    #蒽环类药物#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=3702, encodeId=31f73e0287, content=不错！, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2d50162, createdName=janev21, createdTime=Thu Nov 17 19:01:00 CST 2011, time=2011-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418105, encodeId=7b7514181059a, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3ab3331025, createdName=cy0325, createdTime=Mon Nov 14 15:06:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521681, encodeId=086b1521681da, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Mon Nov 14 15:06:00 CST 2011, time=2011-11-14, status=1, ipAttribution=)]
    2011-11-14 shijzhiewnjhch

    #蒽环类#

    0

相关资讯

蒽环类药物心脏毒性保护剂临床应用的热点问题

蒽环类药物心脏毒性保护剂临床应用的热点问题